Editorial on the article entitled "brigatinib efficacy and safety in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in a phase I/II trial".

ABSTRACT:

SUBMITTER: Sullivan I 

PROVIDER: S-EPMC5107501 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature